Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care.
Addiction is a chronic illness requiring constant vigilance, and relapses are part of the journey to recovery.
Study findings support the continuation of telehealth services for opioid use disorder and related care.
Changes will affect nursing home and hospital staffing, delivery of addiction treatment and COVID data reporting.
These data are consistent with a recent study reporting expansion was not associated with an increase in methadone-involved overdose deaths.
Authorities encourage more health care providers to prescribe buprenorphine for people trying to overcome opioid addiction.
People on opioid substitution therapy were more likely to adhere to antiretroviral treatment and achieve viral suppression.
The potentially lifesaving prescription drug buprenorphine is less available to women and Black and Latino people with opioid addiction.
Overdose deaths rose by nearly 5% in 2019, and the pandemic could make matters worse.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
Researchers examined increasing use of PrEP, expanding access to opioid use disorder treatment and improving engagement with HIV care.
A literature review shows promising signs that teenagers, like adults, can benefit from methadone, buprenorphine and naltrexone.
Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.
The drug can quickly reverse an opioid overdose and prevent death.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.